Core Priority

Training Poster 2024

Building on its successful history of cross-industry training programs that have addressed both
technical skills (such as the Ontology training program) and soft skills (like Diversity & Inclusion in Life
Sciences), the Pistoia Alliance has launched new cross-industry training sessions within a precompetitive framework. These initiatives are shaped by the needs expressed by its members, who
shared their input through a survey conducted at the start of 2024

Lab of the Future Community of Experts

The Pistoia Alliance relaunched the Lab of the Future Community in Q1 2024 to support the growing need for the pharma industry to work together to deliver a clear vision, strategy, and roadmap to guide laboratory investments and accelerate the adoption of disruptive technologies.

UXLS

Our community develops and delivers numerous best practice guides, blogs, and toolkits to increase the adoption of user experience (UX) practices in life sciences.

Annual General Meeting 2024

Agenda

Dr. Becky Upton, President of the Pistoia Alliance

  • Introduction

Dr. Christian Baber, Chief Portfolio Officer, Pistoia Alliance

  • Strategic Priorities Overview
    • Harnessing AI to Expedite R&D
    • Delivering Data-Driven Value
    • Accelerating Use of Real-World Data
    • Sustainability Driven R&D

Strategic Priorities Update June 2024

Join us for this update on the newly formed Strategic Priorities of the Pistoia Alliance, followed by a 30 minutes Q&A with our panelists.

Agenda

Dr Becky Upton, President of the Pistoia Alliance

  • Introduction

Dr Christian Baber, Chief Portfolio Officer, Pistoia Alliance

  • Strategic Priorities Overview
  • Harnessing AI to Expedite R&D
  • Delivering Data-Driven Value

Thierry Escudier, Portfolio Lead, Pistoia Alliance  

  • Accelerating Use of Real-World Data
  • Sustainability Driven R&D

CSCS Community: Reducing Barriers to Research in the UK

Legitimate use of Controlled Drugs, for example for R&D activities, is enabled in the UK through scheduling under the Misuse of Drugs Regulations 2001, which regulates their availability according to their medicinal value and perceived risk of misuse.

In the Misuse of Drugs Act 1971, compounds can be controlled either by (i) name or (ii) a description of a core chemical structure and a range of modifications (generic controls), which provides broad coverage to cover multiple chemicals. Generic controls have been developed and previously recommended by the Advisory Council on Misuse of Drugs (ACMD), who advise the Home Office, to capture groups of compounds that are closely related in structure to known drugs of abuse. ACMD has made recommendations to reduce barriers to research, using compounds described by the third generation synthetic cannabinoid receptor agonists generic definition.

This webinar will cover the background and how the Pistoia Alliance Controlled Substance Compliance and Shipping (CSCS) expert community investigates the potential implications of such proposals.

Speakers
  • Ian Johns, Director Scitegrity
  • Zofia Jordan, Consultant

Digital Transformation and Change Management

Key discussion topics:
  • Why is managing change so critical in digital transformation?
  • What are some of the challenges in a successful rollout?
  • How do you manage change effectively when digital transformation is just one of the changes that people are experiencing?
  • What are the key success factors in effective digital transformation?
 
Facilitator:
  • Kathryn Simpson, Director, Kathryn Simpson Consulting
 
Speakers:
  • Gary Heusner, President, Lextech
  • Sally Walsh, Director, Product Strategy, GSK
  • Paul Denny Gouldson, Principal Consultant, Zifo
  • Adama Ibrahim, Digital Strategy & Change Management, Novo Nordisk

Chemical Safety Library (CSL)

The Pistoia Alliance Chemical Safety Library (CSL) provides unique crowd sourced data content containing hazardous reactions that can be used to alert scientists to potential dangerous experiments. CAS, a division of the American Chemical Society, is committed to increasing safety in the lab and has provided this open access platform to serve scientists worldwide.